UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000032511 |
|---|---|
| Receipt number | R000037066 |
| Scientific Title | The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients |
| Date of disclosure of the study information | 2018/05/09 |
| Last modified on | 2018/05/08 15:55:12 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients
Acronym
The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients
Scientific Title
The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients
Scientific Title:Acronym
The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients
Region
| Japan |
Condition
Condition
chronic renal failure on dialysis
Classification by specialty
| Medicine in general | Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the efficacy of the 23-valent pneumococcal polysaccharide vaccine
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
First admission, or deaths due to all-cause pneumonia or cardiac events.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
consecutive patients undergoing dialysis at any one of the study centers between January 1 and December 31, 2010
Key exclusion criteria
No regular visits
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Nakanobu Azuma |
Organization
Tokatsu-Clinic Hospital
Division name
Director of the Hospital
Zip code
Address
865-2 Hinokuchi; Matsudo-shi, Chiba
TEL
047-364-5121
bcj02422@nifty.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hiroaki Ihara |
Organization
Juntendo University, School of Medicine
Division name
Respiratory Medicine
Zip code
Address
2-1-1 Hongo; Bunkyo-Ku, Tokyo
TEL
03-3813-3111
Homepage URL
h-ihara@juntendo.ac.jp
Sponsor or person
Institute
Tokatsu-Clinic Hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 05 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 03 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 03 | Month | 22 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Cox proportional hazards models were used to compare hazard ratios between the vaccinated and non-vaccinated groups
Management information
Registered date
| 2018 | Year | 05 | Month | 08 | Day |
Last modified on
| 2018 | Year | 05 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037066
